Individualizing Therapy Goals for Patients With Myelofibrosis


Andrew Kuykendall, MD, emphasizes the importance of individualizing therapy for patients with myelofibrosis, focusing on improving quality of life and addressing specific issues like anemia and spleen volume, with the understanding that these treatments are palliative and goals should be revisited regularly.

Related Videos
Naseema Gangat, MBBS
Ashwin Kishtagari, MD
Somedeb Ball, MBBS
Lori A. Leslie, MD
Changchun Deng, MD, PhD
Rebecca Klisovic, MD
Guenther Koehne, MD, PhD
Sunil Iyer, MD
Ibrahim Aldoss, MD
Andrew P. Jallouk, BS, MD, PhD, assistant professor, Vanderbilt University